Wedmont Private Capital Astrazeneca PLC Transaction History
Wedmont Private Capital
- $1.99 Billion
- Q1 2025
A detailed history of Wedmont Private Capital transactions in Astrazeneca PLC stock. As of the latest transaction made, Wedmont Private Capital holds 10,872 shares of AZN stock, worth $791,807. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,872
Previous 10,555
3.0%
Holding current value
$791,807
Previous $691,000
15.63%
% of portfolio
0.04%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.16 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.96 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.59 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.32 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.28 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $226B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...